中新网广州8月23日电 (记者 蔡敏婕)"2025广州医疗与健康产业博览会"(以下简称："广州医博会") 正在广州举行，记者在博览会上看到，智能监测、机器人及精准诊疗技术加速落地。 在广州市红十字会医院主题展区中，烧伤整形科、康复医学科、神经内科等参与主题展示。广州市 红十字会医院副院长宁波在接受中新网采访时表示，面对人口老龄化加剧的社会现状，可穿戴监测系统 成为养老科技的亮点。该系统依托先进算法和软件支撑，能实时监测老年人的血压、呼吸、血糖等基本 体征，在发病前发出预警，第一时间将数据上传至120急诊系统实现预处理，并辅助医生做出治疗决 策。"很多老人缺乏专职照顾，这个系统能在预警阶段及时联系医务人员，为救治争取黄金时间。"宁波 表示。 养老机器人的发展是应对人口老龄化的重要举措，医疗需求为养老机器人提供了明确的功能导向和 应用场景。宁波指出，随着老龄化加深，养老服务需求激增，机器人在生活护理、康复辅助等领域潜力 巨大。"许多心脑血管疾病患者面临失能困境，未来机器人可通过指令完成基础护理工作，替代部分护 工职能。"他坦言，当前养老机器人尚未完全成熟，但未来几年有望实现突破，关键在于医企深度协 同。医院正积极 ...

Group 1 - The 27th China Association for Science and Technology Annual Conference is focusing on major chronic disease prevention and treatment, highlighting advancements in clinical strategies, basic research, and technological innovation [1] - The forum on chronic disease prevention emphasizes the need for a shift in healthcare models from large hospitals to community-based healthcare, promoting a closed-loop system for patient management [1] - Discussions include the exploration of disease mechanisms and the development of personalized treatment plans, particularly in respiratory, cardiovascular, digestive, endocrine, and urinary diseases [1] Group 2 - The "Brain-Computer Interface, Smart Rehabilitation, and Healthy Future" forum addresses the integration of brain-computer interface technology in rehabilitation, focusing on ethical boundaries and clinical translation challenges [2] - Experts discuss key technological bottlenecks in brain-machine interaction, precision rehabilitation assessment, and adaptive algorithms, aiming for interdisciplinary collaborative innovation [2] - The forum's outcomes are expected to enhance the integration of brain-computer interfaces, smart assistive devices, and digital therapies, contributing to the high-quality development of rehabilitation medicine in China [3]

Group 1 - The report identifies ten emerging technologies expected to have significant impacts in the next three to five years, particularly in healthcare, including nanoenzymes, engineered living therapies, GLP-1 drugs for neurodegenerative diseases, and autonomous biochemical sensing [1][2] - The focus on chronic disease management is emphasized, with a large patient base in China facing challenges from aging and younger populations suffering from chronic conditions [3][4] - The global market for nanoenzymes is projected to grow from $5.13 billion in 2024 to $57.95 billion by 2034, reflecting a compound annual growth rate of 27.4% [4] Group 2 - GLP-1 drugs are gaining attention for their potential applications beyond diabetes, including treatment for Alzheimer's and Parkinson's diseases, with a projected market growth to $55.7 billion by 2031 [5] - The report highlights the importance of automated biochemical sensing technology and engineered living therapies in managing chronic diseases, with wearable glucose sensors being a successful application [5][6] - The integration of various technologies, such as engineered living therapies and nanoenzymes, is seen as crucial for addressing health and sustainability challenges [7][8] Group 3 - The report calls for collaboration among business, government, and scientific communities to support the commercialization and responsible governance of these emerging technologies [8] - The global synthetic biology market is expected to grow from $17 billion in 2023 to nearly $50 billion by 2028, with the health sector representing the largest share [9]

Core Viewpoint - The "Four Major Chronic Diseases Major Project" aims to establish a comprehensive mechanism for the prevention and treatment of chronic diseases in China by 2030, focusing on collaboration across various sectors to enhance the accessibility and efficiency of healthcare solutions [1][2]. Group 1: Project Overview - The project is led by Tianjin University of Traditional Chinese Medicine and involves multiple high-level universities, medical institutions, and AI healthcare companies [1][2]. - It aims to create a low-cost, high-efficiency, and widely accessible digital health model for chronic disease prevention and management [2][4]. Group 2: Objectives and Implementation - The project has four specific goals: to build a promotion mechanism for chronic disease prevention technologies, establish a digital platform, develop comprehensive treatment plans for major diseases, and create a new paradigm for integrated health management [2][6]. - It will utilize a collaborative model that integrates government, industry, research, and education to address existing challenges in chronic disease management [2][4]. Group 3: Expert Insights - Academicians emphasized the importance of a comprehensive approach that covers the entire population and disease cycle, aiming for a high-efficiency and low-cost prevention system [4]. - The project is expected to provide a Chinese solution to global health challenges by promoting a combination of traditional and modern medical practices [4][6]. Group 4: Technological Integration - The project will leverage AI and digital technologies to enhance the efficiency and coverage of chronic disease prevention strategies [6][11]. - A digital health community model has been successfully implemented in Tianjin, demonstrating improvements in health indicators and reductions in healthcare costs [7][11]. Group 5: Future Directions - The research outcomes will be implemented across 60 regional urban and rural healthcare networks, promoting the integration of digital solutions in chronic disease management [11][12]. - The project will focus on creating a decision-support system for chronic disease prevention and treatment, utilizing AI and digital platforms for widespread application [11].